Impact of anti-CD20 monoclonal antibodies on serologic response to
Por um escritor misterioso
Descrição
Monoclonal Antibodies: A Tool in Clinical Research - Waliza Ansar, Shyamasree Ghosh, 2013
JCI Insight - Diminished responses to mRNA-based SARS-CoV-2 vaccines in individuals with rheumatoid arthritis on immune-modifying therapies
The applications of anti-CD20 antibodies to treat various B cells disorders - ScienceDirect
Impact of Rituximab and Host/Donor Fc Receptor Polymorphisms after Allogeneic Hematopoietic Cell Transplantation for CD20+ B Cell Malignancies - Biology of Blood and Marrow Transplantation
British Journal of Haematology
Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies
Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study - Tobias Moser, Ciara O'Sullivan, Ferdinand Otto, Wolfgang Hitzl, Georg Pilz, Kerstin Schwenker, Cornelia
Frontiers Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis
Progress with the use of monoclonal antibodies for the treatment of systemic lupus erythematosus
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
de
por adulto (o preço varia de acordo com o tamanho do grupo)
